+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Leuprolide"

Leuprolide Acetate - Global Strategic Business Report - Product Thumbnail Image

Leuprolide Acetate - Global Strategic Business Report

  • Report
  • March 2025
  • 282 Pages
  • Global
From
Leuprolide Acetate Market 2024-2028 - Product Thumbnail Image

Leuprolide Acetate Market 2024-2028

  • Report
  • October 2024
  • 133 Pages
  • Global
From
From
From
From
Prostate Cancer Treatment Drugs Markets in China - Product Thumbnail Image

Prostate Cancer Treatment Drugs Markets in China

  • Report
  • August 2024
  • 244 Pages
  • China
From
  • 9 Results (Page 1 of 1)
Loading Indicator

Leuprolide is a synthetic hormone used to treat prostate cancer. It is a gonadotropin-releasing hormone (GnRH) agonist, meaning it works by blocking the production of testosterone, which can slow the growth of prostate cancer cells. Leuprolide is typically administered via injection, and is available in both short-acting and long-acting formulations. It is often used in combination with other treatments, such as radiation therapy or chemotherapy. Leuprolide is a widely used treatment for prostate cancer, and is often prescribed as a first-line therapy. It is generally well-tolerated, with few side effects. Common side effects include hot flashes, fatigue, and nausea. The leuprolide market is highly competitive, with several major players. These include AbbVie, Astellas Pharma, Endo Pharmaceuticals, and Takeda Pharmaceuticals. Other companies, such as Mylan and Teva Pharmaceuticals, also offer leuprolide products. Show Less Read more